Intravascular Robotics | |
Traded as | NASDAQ: HNSN |
Industry | Medical Appliances & Equipment |
Founded | 2002 |
Headquarters | Mountain View, California, U.S. |
Key people
|
Cary Vance (CEO) |
Products | Sensei Robotic System and Magellan Robotic System |
Website | www |
Hansen Medical, Inc, headquartered in Mountain View, California, designs and manufactures medical robotics for positioning and control of catheter-based technologies. The Company manufactures The Sensei Robotic Catheter System and Artisan Extend Control Catheter to be used in electrophysiology procedures and The Magellan™ Robotic System and Magellan™ Robotic Catheters, indicated for navigation in the peripheral vasculature. Hansen Medical is publicly traded on NASDAQ.
Hansen Medical was founded in 2002 by Frederic Moll, M.D. to develop tools that manipulate catheters by combining robotic technology and computerized movement.
In 2005, Hansen bought EndoVia Medical Inc., a medical robotics company that was started out of the Artificial Intelligence Laboratory at the Massachusetts Institute of Technology and physicians from the Department of Surgery at the Boston University Medical Center. EndoVia's intellectual property included 33 issued and pending patents and patent applications.
Later that year, Hansen Medical and Intuitive Surgical, another company founded by Moll, entered into a cross-licensing agreement that included Hansen's portfolio of 50 issued and pending patents and patent applications and Intuitive's 250 issued patents related to minimally invasive instruments and surgical robotics.
Hansen Medical went public in 2006, raising $75 million in its Initial Public Offering with two catheter systems under FDA review. The shares represented about 30% of the company.
In May 2014, Hansen appointed veteran medical device industry executive Cary Vance as President and Chief Executive Officer. Prior to joining Hansen, Mr. Vance served as President of the Anesthesia & Respiratory global business at Teleflex Inc., Executive Vice President at Covidien Ltd., and Vice President & General Manager at GE Healthcare.
Hansen received FDA clearance, CE mark and shipped the first Sensei® Robotic System in May 2007. First patients were treated with the Magellan Robotic System October 2010. In 2014, the Magellan 6Fr Robotic Catheter became commercially available. In addition, the Sensei X2 Robotic System was launched globally October 2014. Through November 2014, physicians worldwide have performed a cumulative total of more than 15,000 clinical cases using Hansen Medical’s robotic systems.